In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors
Titel:
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors
Auteur:
Brieger, Angela Boehrer, Simone Schaaf, Simone Nowak, Daniel Ruthardt, Martin Kim, Soo-Zin Atadja, Peter Hoelzer, Dieter Mitrou, Paris S Weidmann, Eckhart Chow, Kai Uwe